FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster By Reuters
(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer (NYSE:) Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.